Myricx Enters into Antibody License Agreement with Biocytogen
07 sept. 2023 07h00 HE
|
Myricx Bio
LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development of a completely novel class of selective cytotoxic payloads for...
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
05 sept. 2023 07h00 HE
|
AC Immune SA
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023 Lausanne, Switzerland, September 05, 2023 – AC Immune SA (NASDAQ: ACIU), a clinical-stage...
Global Precision Medicine Market Soars to $100.5 Billion by 2028, Fueled by Personalized Healthcare Demand and Technological Advancements
04 sept. 2023 10h39 HE
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Precision Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global precision medicine market, valued at...
Pharmacogenomics: Global Market Opportunities by Technology, Service, Application, End-user, and Region to 2027
28 août 2023 06h08 HE
|
Research and Markets
Dublin, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Pharmacogenomics Market Size, Share, Trends, Opportunity, and Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. ...
Global CAR T-Cell Therapy Market Size on a Meteoric Rise: Envisioning $2406.39 Million by 2030 with a Striking CAGR of 26.20%
23 août 2023 04h51 HE
|
Zion Market Research
New York, NY, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “CAR T-Cell Therapy Market By Drug Type (Axicabtagene Ciloleucel, Brexucabtagene...
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2023
08 août 2023 07h10 HE
|
SOPHiA GENETICS, Inc.
BOSTON and ROLLE, Switzerland, Aug. 08, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today reported financial...
Global CRISPR Research Report 2023: The Future of Revolutionary Gene Editing Technology - Changing the Landscape of Healthcare and Biotechnology
03 août 2023 05h13 HE
|
Research and Markets
Dublin, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The "Global CRISPR Market by Product (Enzymes, Kits, Libraries), Services (gRNA Design, Cell Line Engineering, Screening), Application (Drug Discovery &...
Extracellular Vesicles & Cell-Free RNAs Conference 2023: Explore the Latest Technologies in EV/Exosomes Research (Laguna Hills, CA - November 28-30, 2023)
24 juil. 2023 06h33 HE
|
Research and Markets
Dublin, July 24, 2023 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles & Cell-Free RNAs 2023" conference has been added to ResearchAndMarkets.com's offering. Experience the future of...
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics Research Report 2023
20 juil. 2023 04h53 HE
|
Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics" report has been added to ResearchAndMarkets.com's offering. The...
GenEmbryomics Engages WallachBeth to Pursue Listing on a US National Stock Exchange
19 juil. 2023 08h00 HE
|
GenEmbryomics
MELBOURNE, Australia, July 19, 2023 (GLOBE NEWSWIRE) -- GenEmbryomics, a medical genetics company with world leading intellectual property, today announced that it has retained WallachBeth Capital...